ASCO 2021: Immunotherapy shows promise in advanced esophageal squamous cell carcinoma
Article written by Bruce Sylvester. Researchers report that both single and dual immunotherapy improve overall survival among patients with advanced esophageal squamous cell carcinoma, particularly those positive for… read more.
